NISPA

Nijmegen Institute for Scientist-Practitioners in Addiction

Publicaties

Resultaten gevonden: 369
[ Auteur(Desc)] Titel Jaar
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Agelink MW, Majewski T, Wurthmann C, Postert T, Linka T, Rotterdam S, Klieser E.  2001.  Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone.. J Affect Disord. 62(3):187-98.
Agelink MW, Majewski T, Wurthmann C, Lukas K, Ullrich H, Linka T, Klieser E.  2001.  Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine.. J Clin Psychopharmacol. 21(1):8-13.
Arends MT, de Haan HA, Van 't Hoff GICM.  2009.  First Dutch national guidelines - pharmacological care for detained opioid addicts. International Journal of Prisoner Health. 5(4):200.
Arends RM, Nelwan EJ, Soediro R, van Crevel R, Alisjahbana B, Pohan HT, A von Borries KL, Schene AH, Van der Ven AJAM, Schellekens AFA.  2019.  Associations between impulsivity, risk behavior and HIV, HBV, HCV and syphilis seroprevalence among female prisoners in Indonesia: A cross-sectional study. PLoS One. 14(2):e0207970.
Arends MT, de Haan HA, Van 't Hoff GICM.  2009.  Medicamenteuze zorg aan gedetineerde verslaafden. Verslaving. 5(3)
Ayu AParawita, Schellekens A, Iskandar S, Pinxten L, DeJong CA.  2015.  The development of an National Training Program on Addiction Medicine in Indonesia. el-Guebaly N, Carrà G, Galanter M (Eds) Textbook of Addiction Treatment: International Perspectives. XII
Ayu AParawita, Iskandar S, Siste K, DeJong CA, Schellekens A.  2016.  Addiction training for health professionals as an antidote to the addiction health burden in Indonesia.. Addiction. 111(8):1498-9.
Ayu AParawita, Schellekens A, Iskandar S, Pinxten L, DeJong CA.  2015.  Effectiveness and Organization of Addiction Medicine Training Across the Globe.. Eur Addict Res. 21(5):223-39.
B
Barrio P, Batalla A, Castellví P, Hidalgo D, García M, Ortiz A, Grande I, Pons A, Parellada E.  2013.  Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.. Int Clin Psychopharmacol. 28(4):164-70.
Batalla A, Garcia-Rizo C, Castellví P, Fernandez-Egea E, Yücel M, Parellada E, Kirkpatrick B, Martin-Santos R, Bernardo M.  2013.  Screening for substance use disorders in first-episode psychosis: implications for readmission.. Schizophr Res. 146(1-3):125-31.
Batalla A, Bhattacharyya S, Yücel M, Fusar-Poli P, Crippa JA, Nogué S, Torrens M, Pujol J, Farré M, Martin-Santos R.  2013.  Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings.. PLoS One. 8(2):e55821.
Batalla A, Ilzarbe D, González J, Soler V.  2012.  [Withdrawal syndrome from abusive consumption of liquid ecstasy precursors].. Med Clin (Barc). 139(4):181-2.
Batalla A, Soriano-Mas C, López-Sola C, Torrens M, Crippa JA, Bhattacharyya S, Blanco-Hinojo L, Fagundo AB, Harrison BJ, Nogué S et al..  2014.  Modulation of brain structure by catechol-O-methyltransferase Val(158) Met polymorphism in chronic cannabis users.. Addict Biol. 19(4):722-32.
Batalla A, Bargalló N, Gassó P, Molina O, Pareto D, Mas S, Roca JM, Bernardo M, Lafuente A, Parellada E.  2015.  Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls.. Transl Psychiatry. 5:e626.
Batalla A, Crippa JA, Busatto GF, Guimaraes FS, Zuardi AW, Valverde O, Atakan Z, McGuire PK, Bhattacharyya S, Martin-Santos R.  2014.  Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review.. Curr Pharm Des. 20(13):2168-85.
Batalla A, Schellekens AFA.  2019.  Hoofdstuk 26 Verslaving en internaliserende problematiek. Handboek Verslaving.
Batalla A, Vera M, Torra M, Parellada E.  2010.  Antipsychotic treatment in a patient with schizophrenia undergoing hemodialysis.. J Clin Psychopharmacol. 30(1):92-4.
Batalla A, Homberg JR, Lipina TV, Sescousse G, Luijten M, Ivanova SA, Schellekens A, Loonen AJM.  2017.  The role of the habenula in the transition from reward to misery in substance use and mood disorders.. Neurosci Biobehav Rev.
Belgers M, Schellekens AFA.  2019.  Hoofdstuk 23 Somatische comorbiditeit bij verslaving. Handboek Verslaving.
Bender S, Grohmann R, Engels RCME, Degner D, Dittmann-Balcar A, Rüther E.  2004.  Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics.. Pharmacopsychiatry. 37 Suppl 1:S46-53.
Bender S, Linka T, Wolstein J, Gehendges S, Paulus HJ, Schall U, Gastpar M.  2004.  Safety and efficacy of combined clozapine-lithium pharmacotherapy.. Int J Neuropsychopharmacol. 7(1):59-63.
Beurmanjer H., Verbrugge CAG, Schrijen S, Schellekens A, DeJong CA, Dijkstra BAG.  2016.  Behandeling van GHB afhankelijkheid na detoxificatie. Eindrapportage NISPA GHB monitor 2.0.
Beurmanjer H, Kamal RM, de Jong CAJ, Dijkstra BAG, Schellekens AFA.  2018.  Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.. CNS Drugs. 32(5):437-442.
Beurmanjer H, Asperslag EM, Oliemeulen L, Goudriaan AE, De Jong CAJ, Schellekens AFA, Dijkstra BAG.  2019.  A Qualitative Approach in Understanding Illness Perception and Treatment Needs in Patients with Gamma Hydroxybutyrate Use Disorder.. Eur Addict Res. 25(5):248-255.
Beurmanjer H., Asperslag E.M., Verbrugge CAG, Oliemeulen L.E.A.P., Schellekens A, DeJong CA, Dijkstra BAG.  2016.  GHB afhankelijkheid: ziektepercepties en behandelingsbehoeftes.

Pagina's